JPH06100450A - 免疫抑制用のキサンチン類 - Google Patents

免疫抑制用のキサンチン類

Info

Publication number
JPH06100450A
JPH06100450A JP3316210A JP31621091A JPH06100450A JP H06100450 A JPH06100450 A JP H06100450A JP 3316210 A JP3316210 A JP 3316210A JP 31621091 A JP31621091 A JP 31621091A JP H06100450 A JPH06100450 A JP H06100450A
Authority
JP
Japan
Prior art keywords
compound
formula
lymphocytes
group
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3316210A
Other languages
English (en)
Japanese (ja)
Inventor
James A Bianco
ジエイムズ・エイ・ビアンコ
Jack W Singer
ジヤツク・ダブリユー・シンガー
William J Novick Jr
ウイリアム・ジエイ・ノビツク・ジユニア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Fred Hutchinson Cancer Center
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Fred Hutchinson Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc, Fred Hutchinson Cancer Center filed Critical Hoechst Roussel Pharmaceuticals Inc
Publication of JPH06100450A publication Critical patent/JPH06100450A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP3316210A 1990-11-30 1991-11-29 免疫抑制用のキサンチン類 Pending JPH06100450A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62048090A 1990-11-30 1990-11-30
US620480 1990-11-30

Publications (1)

Publication Number Publication Date
JPH06100450A true JPH06100450A (ja) 1994-04-12

Family

ID=24486121

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3316210A Pending JPH06100450A (ja) 1990-11-30 1991-11-29 免疫抑制用のキサンチン類

Country Status (10)

Country Link
EP (1) EP0490181A1 (enExample)
JP (1) JPH06100450A (enExample)
KR (1) KR920009399A (enExample)
CA (1) CA2056723A1 (enExample)
HU (1) HUT59825A (enExample)
IE (1) IE914163A1 (enExample)
IL (1) IL100195A0 (enExample)
PT (1) PT99659A (enExample)
TW (1) TW205507B (enExample)
ZA (1) ZA919438B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2109796C (en) * 1991-05-24 2004-04-27 James A. Bianco Modulation of cellular response to external stimuli
DE4411660A1 (de) * 1994-04-05 1995-10-12 Hoechst Ag Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung
DE4430127A1 (de) * 1994-08-25 1996-03-14 Hoechst Ag Kombinationspräparat, enthaltend Cyclosporin A oder FK506 und ein Xanthinderivat
DE4430128A1 (de) * 1994-08-25 1996-02-29 Hoechst Ag Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen
US6323201B1 (en) 1994-12-29 2001-11-27 The Regents Of The University Of California Compounds for inhibition of ceramide-mediated signal transduction
DE69812070T2 (de) * 1998-04-24 2003-12-11 K.U. Leuven Research & Development, Leuven Immununterdrückende Effekte von 8 substituierten Xanthinderivaten
US6930101B1 (en) 1999-05-17 2005-08-16 The Regents Of The University Of California Thiazolopyrimidines useful as TNFα inhibitors
US7253176B1 (en) 2000-05-04 2007-08-07 K.U. Leuven Research & Development Immunosuppressive effects of 8-substituted xanthine derivatives
EP2265334A2 (en) 2008-02-29 2010-12-29 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
EP2473052A4 (en) 2009-09-02 2013-03-20 Concert Pharmaceuticals Inc SUBSTITUTED XANTHINE DERIVATIVES
US20130324564A1 (en) 2010-09-01 2013-12-05 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)-dione
WO2013013052A1 (en) 2011-07-19 2013-01-24 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
CN104364255A (zh) 2012-04-13 2015-02-18 康塞特医药品有限公司 取代的黄嘌呤衍生物
WO2013159006A1 (en) 2012-04-20 2013-10-24 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione
US9549869B2 (en) 2012-06-29 2017-01-24 Hill-Rom Canado Respiratory Ltd. Wearable thorax percussion device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063827B1 (fr) * 1980-05-02 1985-08-14 Societe Des Produits Nestle S.A. 1-Isopropyl- et 1-isobutyl-3,7-diméthylxanthine comme médicaments
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
IL106861A (en) * 1986-12-31 1997-02-18 Hoechst Roussel Pharma Pentoxifylline metabolites and pharmaceutical formulations containing them for inhibiting the activity of interleukin-1 and leukocyte-derived cytokines
GB8918297D0 (en) * 1989-08-10 1989-09-20 Beecham Group Plc Novel treatment

Also Published As

Publication number Publication date
EP0490181A1 (en) 1992-06-17
IE914163A1 (en) 1992-06-03
PT99659A (pt) 1992-10-30
TW205507B (enExample) 1993-05-11
HU913721D0 (en) 1992-02-28
ZA919438B (en) 1992-08-26
KR920009399A (ko) 1992-06-25
IL100195A0 (en) 1992-08-18
CA2056723A1 (en) 1992-05-31
HUT59825A (en) 1992-07-28

Similar Documents

Publication Publication Date Title
JPH06100450A (ja) 免疫抑制用のキサンチン類
US5096906A (en) Method of inhibiting the activity of leukocyte derived cytokines
EP0483634B1 (en) An aminoglycoside composition having substantially reduced nephrotoxicity induced by the amino glycoside
US5272153A (en) Method of inhibiting the activity of leukocyte derived cytokines
US5244896A (en) Carbocyclic adenosine analogs useful as immunosuppressants
AU668982B2 (en) Method of inhibiting activity of leukocyte derived cytokines
JPH08259565A (ja) 鏡像異性体ヒドロキシル化キサンチン化合物
HUT77436A (hu) Purin- és guaninszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk gyógyszerkészítmények előállítására
CA2051012C (en) Carbocyclic adenosine analogs useful as immunosupressants
US6420374B1 (en) Use of xanthines as immunosuppressants and to inhibit allograft reactions
JPH0525048A (ja) 異型移植反応阻止用のキサンチン類
EP0484785B1 (en) Use of xanthines for the preparation of a medicament effective for inhibiting the replication of human retroviruses
US5605903A (en) Carbocyclic nucleoside analogs useful as immunosuppressants
JPH08512281A (ja) アデノシンａ▲下１▼受容体拮抗剤としてのキサンチン誘導体類
EP0475413B1 (en) Carbocyclic nucleoside analogs useful as immunosuppressants
US20230381174A1 (en) Thionoester-derivative of rabeximod for the treatment of inflammatory and autoimmune disorders
AU619732C (en) Method of inhibiting interleukin-1 activity
JPH04244027A (ja) 免疫抑制剤としての５’−ビニルハロ−アリステロマイシン／アデノシン類似体類
CN101495479A (zh) 咪唑并氮杂环庚烯酮化合物